Global Radiopharmaceuticals Strategic Analysis Report 2023-2030: Shaping the Future of Healthcare - Precision Medicine Powered by Radiopharmaceuticals

News provided by

Oct 09, 2023, 11:15 ET

DUBLIN, Oct. 9, 2023 /PRNewswire/ -- The "Radiopharmaceuticals - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.

Global Radiopharmaceuticals Market to Reach $14.3 Billion by 2030

The global market for Radiopharmaceuticals estimated at US$6.3 Billion in the year 2022, is projected to reach a revised size of US$14.3 Billion by 2030, growing at a CAGR of 10.8% over the analysis period 2022-2030.

This analysis provides insights into the historical performance, current status, and future projections for radioisotopes across various applications, including oncology, cardiology, endocrine tumors, neurology, and more. The report offers a 14-year perspective on sales percentages for 2016, 2023, and 2030, delivering valuable insights into market trends and dynamics.

Within the report, the SPECT Radioisotopes segment is expected to achieve a remarkable 10.4% CAGR, reaching a market value of US$6.2 billion by the end of the analysis period. Additionally, the Pet Radioisotopes segment is projected to grow at a strong 9.8% CAGR over the next eight years.

The U.S. market is estimated at US$3.1 billion in 2022, while China, as the world's second-largest economy, is forecasted to attain a market size of approximately US$1.2 billion by 2030, with an impressive CAGR of 13.9% during the 2022-2030 analysis period.

The global SPECT and PET radioisotopes market is comprehensively evaluated in this report, focusing on annual sales data from 2016 to 2030 and encompassing various geographic regions, including the USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, the Middle East, and Africa.

Furthermore, the report provides detailed insights into the competitive landscape, including prominent names like Bayer HealthCare Pharmaceuticals, GE Healthcare, and Actinium Pharmaceuticals, Inc., to enhance your strategic planning initiatives.

What`s New?

Special discussions on the global economic climate and market sentiment
Coverage on global competitiveness and key competitor percentage market shares
Market presence analysis across multiple geographies - Strong/Active/Niche/Trivial
Online interactive peer-to-peer collaborative bespoke updates
Access to digital archives and trademarked research platform
Complimentary updates for one year
Access to curated YouTube video transcripts of market sentiments shared by CEOs, domain experts and market influencers via interviews, podcasts, press statements and event keynotes

MARKET OVERVIEW

Radiopharmaceuticals: A Prelude
Mechanism of Action
Global Economic Update
From Pandemic to War & Inflation: "Subdued Outlook for 2023 Despite Signs of Easing Inflationary Conditions"
Here's How Inflationary Pressures Affect the Economy
Although Past Peak in 2023, Efforts to Solve the Inflation Puzzle Should Continue
Slower Than Anticipated Decline Makes Inflation a Stickier Than Expected Problem to Solve in 2023: Global Inflation Rates (In %) for the Years 2019 Through 2024
Global Economy Faces a Tough Climb Towards Recovery Made Rockier by the War, Anti-Inflation Fiscal Policies & Slower Than Desirable Easing of Inflationary Pressures: World Economic Growth Projections (Real GDP, Annual % Change) for the Years 2020 Through 2024
Pandemic-Led Disruptions Affect Radiopharmaceuticals Supply
Imaging Screening Volume % Change 1H 2019 Vs 1H 2020 in US Hospitals
Hospitals Struggle as Distribution Bottlenecks Affect Supply of Medical Radioisotopes
Nuclear Medicine Services Back to Normal
Pandemic Presents Generational Opportunity
Global Market Outlook
Key Market Drivers
Market Restraints
Recognition of Intrinsic Cost Benefits: Critical to Market Acceptance
Classification of Radiopharmaceuticals
Diagnostic Radiopharmaceuticals: The Dominant Segment
Positron Emission Tomography (PET)
Single Photon Emission Computed Tomography (SPECT)
Therapeutic Radiopharmaceuticals
Supply Shortages Remain a Challenge to Market Growth
A Glimpse at Mo-99 Processors Worldwide
Nuclear Research Reactor Irradiators Worldwide: A Snapshot
Competition
Radiopharmaceuticals - Global Key Competitors Percentage Market Share in 2023 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2023 (E)
Recent Market Activity

MARKET TRENDS & DRIVERS

Emergence of Radiotheranostics: Dual-Functioning Radiopharmaceuticals
Radiopharmaceuticals Become Promising for Cancer Theranostics
Changing Role of Radiopharmaceuticals in Diagnostic and Therapeutic Applications
Notable Clinical Applications of Radiopharmaceuticals in Nuclear Medicine
Advent of New Radiopharmaceuticals Widen Scope
Startups Develop Unique Radiopharmaceutical Solutions
Potential Role of Carbon Dots in Imaging and Theranostics
Nano Radiopharmaceuticals: Promising Role in Therapeutic and Imaging Applications
Current Major Focus Areas in Radiopharmaceutical Research
R&D Efforts in the Radiopharmaceuticals Market
Researchers Develop New Nanoparticles to Improve Radiopharmaceutical Efficiency
Oncoinvent and NPL Develop Unique Method to Measure & Deliver Dosages in Radiotherapy
Researchers Develop S-Value Database for Simplifying Complexity in Tumor Dosimetry
Key Impediments in Academic Research of Radiopharmaceuticals
Industry Gears up for Innovative Radiopharmaceuticals with Therapeutic Benefits
Role of Radiopharmaceuticals as Diagnostic Technology
Promising Molecular Imaging Technology Advancements for SPECT and PET
PET Eclipses SPECT in Cardiovascular Imaging
Worldwide Installed Base of Nuclear Imaging Equipment by Modality, PET Vs SPECT: 2023E
Cardiac Amyloidosis Visualization: A Potential Application for PET
Innovative Radiopharmaceuticals to Boost Cardiac Applications
Fatalities by Heart Conditions - Estimated Percentage Breakdown for Cardiovascular Disease, Ischemic Heart Disease, Stroke, and Others
Global Annual Medical Cost of Cardiovascular Diseases in US$ Billion (2010-2030)
Radiopharmaceuticals: Direct and Targeted Approach for Cancer Treatment
Increased Use of Radiopharmaceuticals Across Oncology to Drive Market Growth
Rising Cancer Incidence Worldwide Spurs Demand
Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
Global Number of New Cancer Cases and Cancer-related Deaths by Cancer Site for 2020
Number of New Cancer Cases and Deaths (in Million) by Region for 2020
Intra-Operative Lymphatic Mapping (ILM) Creates New Opportunities for Radiopharmaceuticals in Cancer Detection
Growing Prominence of Therapeutic Radiopharmaceuticals for Cancer Care
Radiopharmaceuticals Expand Horizons for Cancer Treatment Arena
Radiopharmaceuticals as Potential Silver Bullet to Target & Treat Prostate Cancer
Challenges with Radiopharmaceuticals for Cancer
Rise in Incidence of Neurological Disorders to Drive Growth
Application of PET in Drug Development to Expand Opportunities
Personalized Medicine Drives Nuclear Medicine
Drug Ineffectiveness for Select Therapeutic Categories as a Percentage of Patient Population
Global Personalized Medicines Market (in US$ Billion) for the Years 2022, 2025 and 2028
Need for Guidance for Manufacture of Investigational Radiopharmaceuticals for Clinical Trials
Technetium-99m to Hold Immense Potential for Use in Diagnostic Nuclear Medicine in the Future
Shortage of 99Mo and 99mTc to Adversely Impact Provider Care and Patient Access
Novel Production Method Promises to End Problems of 99mTc Shortages
New Approach for Production of Clinical Radiopharmaceuticals
Gallium-68-labeled Radiopharmaceuticals: Production & Administering Challenges
Radiopharmaceuticals for COVID-19: Role in Diagnosis, Prognosis, and Therapeutic Uses
Arti?cial Intelligence: A Promising Tool in Radiotherapy and Radiopharmaceuticals
Nuclear Medicine & AI to Power the Future of Precision Medicine
Aging Global Population: A Vital Demography
Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
Rise in Healthcare Expenditure to Drive Growth
World Healthcare Expenditure (In US$ Trillion) for the Years for 2017, 2019, 2021 & 2023
Relevant Aspects of Radiopharmaceutical Production
Regulatory Regime Governing Production and Use of Radiopharmaceuticals
The Facilitating Innovative Nuclear Diagnostics (FIND) Act, 2021
Challenges Facing Nuclear Medicine Industry

FOCUS ON SELECT PLAYERS (Total 141 Featured)

Actinium Pharmaceuticals, Inc.
Advanced Accelerator Applications
Alliance Medical Ltd.
Bayer HealthCare Pharmaceuticals
Bracco Diagnostics, Inc.
Cardinal Health, Inc.
Curium US LLC
GE Healthcare
IBA Radiopharma Solutions
Jubilant DraxImage Inc.
Lantheus Medical Imaging Inc.
Medi-Radiopharma Ltd.
Nordion Inc.
Radiopharm Theranostics Ltd.
Siemens Healthcare GmbH

For more information about this report visit https://www.researchandmarkets.com/r/o8jm6m

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

SOURCE Research and Markets